Kiadis Pharma

  • Kiadis Pharma floated on Euronext Amsterdam and Euronext Brussels
  • Proceeds of the IPO will be used to advance the clinical development of the lead products
  • Kempen & Co acted as Sole Global Coordinator and Joint Bookrunner in the transaction